Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse drug interactions clinically important for the dermatologist

W K Andersen1, D S Feingold

  • 1Department of Dermatology, Boston University Medical Center, Mass., USA.

Archives of Dermatology
|April 1, 1995
PubMed
Summary

Dermatologists face risks from harmful drug interactions. This review identifies dangerous drug combinations and vulnerable patients to improve safety in dermatologic prescriptions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atlas of infections of the skin.

Archives of dermatology·2014
Same author

The mechanism of colicin E 1 action.

The Journal of membrane biology·2013
Same author

Locus of the catalytic sites of udp-glucose dehydrogenase in the native enzyme hexamer as delineated by fluorescence energy transfer.

Biophysical journal·2009
Same author

Gianotti-Crosti syndrome presenting as lichenoid dermatitis.

The American Journal of dermatopathology·2000
Same author

Glenohumeral motion in patients with rotator cuff tears: a comparison of asymptomatic and symptomatic shoulders.

Journal of shoulder and elbow surgery·2000
Same author

Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR/DGGE)-based detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded cutaneous biopsies in cutaneous T-cell lymphoproliferative diseases.

Journal of cutaneous pathology·1999

Area of Science:

  • Dermatology
  • Pharmacology
  • Drug Safety

Background:

  • Physicians, including dermatologists, are susceptible to prescribing harmful drug combinations.
  • Adverse drug interactions can lead to severe consequences, yet specific concerns for dermatologists are not well-reviewed.
  • Understanding these interactions is crucial for patient safety.

Purpose of the Study:

  • To review the pharmacologic mechanisms of adverse drug interactions relevant to dermatology.
  • To identify high-risk drugs and vulnerable patient populations in dermatologic care.
  • To provide guidance for navigating potential drug-drug interactions.

Main Methods:

  • Review of adverse drug interactions involving common dermatologic medications.
  • Focus on interactions between methotrexate, cyclosporin A, antifungals, antibiotics, retinoids, and antihistamines.

Related Experiment Videos

  • Examination of interactions with other systemic medications.

    • Main Results:

    • Sparse epidemiologic data exists on the prevalence and cost of adverse drug interactions in dermatology.
    • Consequences range from reduced therapeutic effect to life-threatening reactions.
    • Identified key drug classes frequently used in dermatology that pose interaction risks.

    Conclusions:

    • An organized reporting system is needed to gather statistically significant data on adverse drug interactions.
    • Programs like Medwatch can provide valuable insights into dangerous drug combinations.
    • Establishing such systems is vital for addressing drug interaction risks as a public health issue.